Catalyst Health Ventures
Boston, Massachusettschv.vc
Overview
Catalyst Health Ventures (CHV) is an early-stage venture capital firm that invests in transformative medical technologies. The firm focuses on therapeutic medical devices, diagnostics, and digital health, aiming to address unmet global healthcare needs. CHV typically partners with companies from the seed to Series B stages, often acting as the first institutional investor, and provides hands-on guidance and collaborative support to its portfolio companies.
Portfolio Companies
12
Website
chv.vcInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Rejoni, Inc. | Jun 2026 | VC Round | Co-investor |
| AtaCor Medical | Oct 2025 | Financing | Co-investor |
| PanTher Therapeutics | Apr 2025 | Series B | Lead |
| Esperto Medical | Feb 2025 | Series A | Lead |
| Venova Medical, Inc. | Sep 2024 | Series B | Lead |
Key People
Joshua Phillips
Managing General Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
